Ancylostomiasis clinical trials
The registry lists 41 studies for Ancylostomiasis across more than 10 countries. 2 are recruiting or about to start. 10 of them are mainly about Ancylostomiasis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-08.
Get an email when these change. Save the Ancylostomiasis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Baylor College of Medicine (9) · Jennifer Keiser (7) · Albert B. Sabin Vaccine Institute (3) · London School of Hygiene and Tropical Medicine (3) · Swiss Tropical & Public Health Institute (3) · University Ghent (2) · Leiden University Medical Center (2) · Centre de Recherche Médicale de Lambaréné (1)
What is being tested here
Drugs under test in Ancylostomiasis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Emodepside | 1 | 2 | 4 |
| Ivermectin | 0 | 3 | 4 |
| Albendazole | 0 | 2 | 4 |
| Moxidectin | 0 | 3 | 3 |
| Mebendazole | 0 | 1 | 3 |
| Necator americanus | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Jun 2027Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections · Phase 3 · Swiss Tropical & Public Health Institute
Who these studies take
No Ancylostomiasis study is recruiting now.
Across all 41 studies, recruiting or not: 83% stop at 75 or younger and 83% at 65; 59% take children; 2% are for women only and 0% for men only; 66% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 41 of 41. search them.
- Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth InfectionsNot yet recruitingNCT06800248Phase 31 country
- Immune Responses in the Skin After Hookworm InfectionNot yet recruitingNCT06478498Not applicable1 country
- Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth InfectionsCompletedNCT06736691Phase 31 country
- Community Health Education and Hygiene Promotion Added to Deworming Among Ethnic Khmer Children in VietnamCompletedNCT07855978Not applicable1 country
- Efficacy, Safety and Acceptability of Ivermectin ODT in PSACCompletedNCT06184399Phase 21 country
- Efficacy and Safety of Moxidectin-Albendazole Co-administration in SACCompletedNCT06188715Phase 31 country
- Safety and Immunogenicity Study of Na-GST-1 With or Without CpGCompletedNCT02143518Phase 11 country
- Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese ChildrenCompletedNCT02839161Phase 11 country
- Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel AdjuvantCompletedNCT01385189Phase 11 country
- Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administrationCompletedNCT04700423Phase 2/31 country
- Efficacy and Safety of MOX/ALB Co-administrationCompletedNCT04726969Phase 31 country
- Monitoring Drug Efficacy and Anthelmintic Resistance in Soil-transmitted Helminth ProgramsCompletedNCT041776548 countries
- Efficacy and Safety of Emodepside in Adolescents and Adults Infected With HookwormCompletedNCT05538767Phase 21 country
- Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and HookwormCompletedNCT05017194Phase 21 country
- Adjunctive Ivermectin Mass Drug Administration for Malaria ControlStatus unknownNCT04844905Phase 31 country
- Establishing a Controlled Human Hookworm Infection Model at Leiden University Medical CenterCompletedNCT03126552Not applicable1 country
- Hookworm Immune Regulation ProjectStatus unknownNCT02262403Not applicable1 country
- Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese AdultsCompletedNCT03373214Phase 11 country
- Repeated Controlled Human Hookworm InfectionCompletedNCT03257072Not applicable1 country
- Validation of INSPiRED Innovative Smart Diagnostic Devices for the Detection of Parasites Infections.Status unknownNCT045050461 country
- Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against HookwormCompletedNCT03995680Phase 21 country
- Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian AdultsCompletedNCT02476773Phase 11 country
- Validating Egg-based Diagnostics and Molecular Markers for the Spread of Anthelmintic ResistanceCompletedNCT03465488Not applicable4 countries
- Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy AdultsCompletedNCT01717950Phase 11 country
- Efficacy and Safety of a Multi-dose Regimen of Mebendazole Against Hookworm in ChildrenCompletedNCT03245398Phase 41 country
- Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in KenyaCompletedNCT02397772Phase 41 country
- Prevalence of Hookworm Infection and Community Preparedness for Hookworm Vaccine Trials in Endemic Areas of BrazilCompletedNCT00939198Not applicable1 country
- Mebendazole Study Against Hookworm Infections in Children and Adolescents in GhanaWithdrawnNCT03261596Phase 41 country
- Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian AdultsCompletedNCT01261130Phase 11 country
- Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm InfectionCompletedNCT00120081Phase 11 country
- Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese AdultsCompletedNCT02126462Phase 11 country
- Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School ChildrenCompletedNCT01658774Not applicable1 country
- Desensitising Celiac Disease Patients With the Human HookwormCompletedNCT01661933Phase 1/21 country
- Impact of Health Education on School ChildrenCompletedNCT01640626Phase 11 country
- Does Treating Hookworm Improve Productivity of Small Subsistence FarmersStatus unknownNCT02102321Not applicable1 country
- Study to Test Whether Shoes Protect Children Against Hookworm Infection on Pemba Island, ZanzibarCompletedNCT01869127Not applicable1 country
- Comparative Efficacy of Different Mebendazole Polymorphs in the Treatment of Soil-transmitted Helminth InfectionsCompletedNCT01350271Phase 31 country
- Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian AdultsTerminatedNCT00473967Phase 11 country
- Development of a Skin Test for the Na-ASP-2 Hookworm AntigenCompletedNCT00603889Not applicable1 country
- Education Intervention to Reduce Helminth Infections and Absenteeism in Grade 5 School-childrenCompletedNCT01085799Not applicable1 country
- Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm InfectionsCompletedNCT00207753Not applicable1 country